Rapid Response

Body Mass Index Is Not Predictive of Ovarian Cancer Survival

Authors: Catherine M. Olsen, PhD, MPH, BSc, Christina M. Nagle, PhD, MPH, BappSc


In the largest ovarian cancer survival study to date, Barrett et al found no association between body mass index at first treatment and progression-free or overall survival. These findings add to the growing body of evidence that obesity does not have an adverse effect on the survival of women with ovarian cancer.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.